<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJMC</journal-id><journal-title-group><journal-title>Open Journal of Medicinal Chemistry</journal-title></journal-title-group><issn pub-type="epub">2164-3121</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojmc.2023.131001</article-id><article-id pub-id-type="publisher-id">OJMC-124962</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Physicochemical Properties and Biological Activities of Novel Hydrazonate Copper Complexes
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sommai</surname><given-names>Patitungkho</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kingkaew</surname><given-names>Patitungkho</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Chemistry, Faculty of Science, Buriram Rajabhat University, Buriram, Thailand</addr-line></aff><aff id="aff2"><addr-line>Department of Library &amp;amp; Information Science, Buriram Rajabhat University, Buriram, Thailand</addr-line></aff><pub-date pub-type="epub"><day>31</day><month>03</month><year>2023</year></pub-date><volume>13</volume><issue>01</issue><fpage>1</fpage><lpage>13</lpage><history><date date-type="received"><day>6,</day>	<month>March</month>	<year>2023</year></date><date date-type="rev-recd"><day>28,</day>	<month>March</month>	<year>2023</year>	</date><date date-type="accepted"><day>31,</day>	<month>March</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The objective of this research was to elucidate the biological effect of novel compounds derived from natural product of syringaldehyde through novel
   
  semi-synthetic method in order to investigate the physicochemical properties and biological activities by using DPPH and FRAP techniques and its antibacterial activities against Klebsiella spp., Pseudomonas aeruginosa, Bacillus cereus, and Staphylococcus aureus. Moreover, to examine its ability against breast cancer cell line (MCF-7). The results showed that the syringaldehyde hydrazonate copper complexes possessed the covalent bonds with square-planar structure. In terms of antioxidant DPPH activities, it was found that syringaldehyde hydrazone possessed high potency against DPPH free radicals, with respect to syringaldehyde hydrazonate copper complexes. On the other hand, all compounds possessed low reducing properties for changing Fe<sup>3+</sup> to Fe<sup>2+</sup> in FRAP technique. For antibacterial activities
  <b> </b>
  revealed that the ligand <b>L1 </b>and <b>L5</b> possessed high effect 
  on
   Pseudomonas aeruginosa, but for all copper complexes possessed high potent antibacterial susceptibility to four bacteria with concentration dependence. For anti-breast cancer cell line (MCF-7), it was found that all compounds possessed high potent anticancer susceptibility with low IC<sub>50</sub>, especially, compound exhibit highly potency effective is <b>C5</b> (IC<sub>50</sub> 9.75 μM). The tendency of anticancer effect from high to low was <b>C5</b> &gt; <b>C2</b> &gt; <b>C1</b> &gt; <b>C4</b> &gt; <b>C3</b>. Therefore, all synthetic compounds obtained from the present research possibly develop as the antibacterial drugs and the drugs for curing the diseases caused by free radicals, including breast cancer in metastatic phase. The most important feature of these drugs was the high specificity to the target and harmless to the normal cells.
 
</p></abstract><kwd-group><kwd>Schiff Base</kwd><kwd> Hydrazone</kwd><kwd> Natural Product</kwd><kwd> Anticancer</kwd><kwd> Antibacterial</kwd><kwd> Anti-Free Radical</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cancer causes from the mutation of genes that allow cells to divide unrestrictedly. Acquisition mutations can be caused by genetics (inherited) or other external factors. Acquired mutations are caused by conditions that are constantly triggered such as smoking or exposure to UV rays, and sometimes it can be caused by years of exposure to carcinogens [<xref ref-type="bibr" rid="scirp.124962-ref1">1</xref>] . When these risk factors are combined with other risk factors, many more, thus make it difficult to diagnose the real cause of cancers. But the most important thing is risk factors such as carcinogens, chemicals or dietary components, should be avoided [<xref ref-type="bibr" rid="scirp.124962-ref2">2</xref>] , consumption of alcoholic beverages, and a diet high in fat and low in fiber, which is directly linked to the development of many cancers. But should consume a variety of vegetables and fruits, because it contains antioxidants and micronutrients necessary for health [<xref ref-type="bibr" rid="scirp.124962-ref3">3</xref>] . Normally, when the body is exposed to carcinogens, it doesn’t happen immediately because DNA has a mechanism to repair it [<xref ref-type="bibr" rid="scirp.124962-ref4">4</xref>] . But if the body is exposed to carcinogens on a regular basis, it can result in mutations or changes in genes that cause cancer called oncogenes and also affect the tumor-suppressor genes such as p16, p53 and BRCA 1, which signal cells stop dividing. In the abnormal condition, tumor-suppressor genes are not stimulated to work but oncogene is, affecting the cell is grown and continuously developed [<xref ref-type="bibr" rid="scirp.124962-ref5">5</xref>] . This makes people die of cancer with the approximate number of 50,000 people per year. For the treatment of cancer today is still difficult to treat [<xref ref-type="bibr" rid="scirp.124962-ref6">6</xref>] . Even trying to develop a drug and modern tools but it can’t be detected while the cancer cells are still small or in the early stages [<xref ref-type="bibr" rid="scirp.124962-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.124962-ref8">8</xref>] . Existing treatment methods, such as surgery, will work well. If detected in the early stages, there is also radiation and chemical use as well [<xref ref-type="bibr" rid="scirp.124962-ref9">9</xref>] . Depending on the diagnosis of a skilled physician. As for chemotherapy, it is considered one of the important treatments for this disease [<xref ref-type="bibr" rid="scirp.124962-ref10">10</xref>] . But the drugs that are currently used only provide relief from the symptoms. In addition, some drugs have many side effects because they lack specificity to cancer cells. And some types develop drug resistance when used to treat patients for a long time [<xref ref-type="bibr" rid="scirp.124962-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.124962-ref12">12</xref>] . In addition to the aforementioned cancer, there is another disease that is a global public health problem, such as a disease caused by bacteria [<xref ref-type="bibr" rid="scirp.124962-ref13">13</xref>] , especially diseases caused by infection Staphylococcus aureus because it is currently resistant to methicillin [<xref ref-type="bibr" rid="scirp.124962-ref14">14</xref>] . Patients with this infection are difficult to treat. Therefore, the research team has tried to develop researching new, more effective substances are specific to destroying cancer cells that are not toxic to normal cells and it’s not too expensive. Substances such as Schiff bases and Schiff bases conjugated with essential metal elements make the new compounds specific to the target cells. The bioactivity against bacteria of these compounds was also studied.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Chemical Reagents and Bacteria</title><p>All chemicals were purchased from Sigma-Aldrich, Fluka and Agar Powder, reagent grade and were used as received. For bacteria test strains both Gram-negative (Klebsiella spp. and Pseudomonas aeruginosa) and Gram-positive (Bacillus cereus and Staphylococcus aureus) were obtained from Department of Microbiology, Khon Kaen University.</p></sec><sec id="s2_2"><title>2.2. Synthesis Hydrazone Ligands or Schiff Bases</title><p>All ligands were prepared by condensation of syringaldehyde with one of the five hydrazides indicated (Scheme 1) in the molar ratio 1:1 in MeOH (5 ml) with constant stirring at 40˚C for 6 hrs and concentrating the reaction mixture before allowing it to cool at room temperature. The products were obtained with high percentages of the yield as shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p></sec><sec id="s2_3"><title>2.3. Synthesis Copper Complexes</title><p>Copper (II) chloride dihydrate was added to the methanolic solution of syringaldehyde hydrazones in the molar ratio of 1:1 over a period of 3 hrs with constant stirring in dark. The products were separated by centrifugation and dried in vacuum.</p></sec><sec id="s2_4"><title>2.4. Antioxidant Activity by DPPH Method</title><p>The assay was performed as described Sharma et al. [<xref ref-type="bibr" rid="scirp.124962-ref15">15</xref>] , the DPPH radical scavenging activity of the compounds was measured. Briefly, 0.2 mM 2,2-Diphynyl-1-picrylhydrazyl (DPPH) solution was prepared with methanol. 100 &#181;L sample was added to 3.9 cm<sup>3</sup> DPPH solution and was incubated in dark for 30 min at a temperature of 37˚C then the absorbance was measured at λ<sub>max</sub> = 517 nm, calculate the percentage of anti-free radical activities.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Physicochemical properties of samples</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Trivial name</th><th align="center" valign="middle" >Code</th><th align="center" valign="middle" >Percent yield</th><th align="center" valign="middle" >Melting point (˚C)</th><th align="center" valign="middle" >Color of samples</th><th align="center" valign="middle" >Solvents</th></tr></thead><tr><td align="center" valign="middle" >1. SRA-Sc</td><td align="center" valign="middle" >L1</td><td align="center" valign="middle" >82</td><td align="center" valign="middle" >103.1</td><td align="center" valign="middle" >brown</td><td align="center" valign="middle" >MeOH, DMSO, DMF</td></tr><tr><td align="center" valign="middle" >2. SRA-Sc-Cu</td><td align="center" valign="middle" >C1</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >134.0</td><td align="center" valign="middle" >green</td><td align="center" valign="middle" >MeOH, DMSO, DMF</td></tr><tr><td align="center" valign="middle" >3. SRA-Tsc</td><td align="center" valign="middle" >L2</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >116.2</td><td align="center" valign="middle" >yellow</td><td align="center" valign="middle" >MeOH, DMSO, DMF</td></tr><tr><td align="center" valign="middle" >4. SRA-Tsc-Cu</td><td align="center" valign="middle" >C2</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >178.7</td><td align="center" valign="middle" >green</td><td align="center" valign="middle" >MeOH, DMSO, DMF</td></tr><tr><td align="center" valign="middle" >5. SRA-INH</td><td align="center" valign="middle" >L3</td><td align="center" valign="middle" >91</td><td align="center" valign="middle" >218.9</td><td align="center" valign="middle" >yellow</td><td align="center" valign="middle" >MeOH, DMSO, DMF</td></tr><tr><td align="center" valign="middle" >6. SRA-INH-Cu</td><td align="center" valign="middle" >C3</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >198.7</td><td align="center" valign="middle" >green</td><td align="center" valign="middle" >MeOH, DMSO, DMF</td></tr><tr><td align="center" valign="middle" >7. SRA-Nico</td><td align="center" valign="middle" >L4</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >218.8</td><td align="center" valign="middle" >white</td><td align="center" valign="middle" >MeOH, DMSO, DMF</td></tr><tr><td align="center" valign="middle" >8. SRA-Nico-Cu</td><td align="center" valign="middle" >C4</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >211.4</td><td align="center" valign="middle" >green</td><td align="center" valign="middle" >MeOH, DMSO, DMF</td></tr><tr><td align="center" valign="middle" >9. SRA-Sal</td><td align="center" valign="middle" >L5</td><td align="center" valign="middle" >87</td><td align="center" valign="middle" >233.4</td><td align="center" valign="middle" >brown</td><td align="center" valign="middle" >MeOH, DMSO, DMF</td></tr><tr><td align="center" valign="middle" >10. SRA-Sal-Cu</td><td align="center" valign="middle" >C5</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >288.9</td><td align="center" valign="middle" >green</td><td align="center" valign="middle" >MeOH, DMSO, DMF</td></tr></tbody></table></table-wrap></sec><sec id="s2_5"><title>2.5. Antioxidant Activity by FRAP Method</title><p>Prepare FRAP (ferric reducing/antioxidant power) by preparing acetate buffer pH 3.6, 10 mM TPTZ (2, 4, 6-tripyridly-s-trizine) in solution 40 mM of HCL, and 20 mM of ferric chloride and then mix at the proportion of 10:1:1 (v/v). This will get FRAP solution, then prepare sample solution in purified water with the required concentrations [<xref ref-type="bibr" rid="scirp.124962-ref15">15</xref>] .</p></sec><sec id="s2_6"><title>2.6. Antibacterial Activities</title><p>All the newly synthesized compounds were screened for antibacterial activity against both gram-negative (Pseudomonas aeruginosa and Klebsiella spp.) and gram-positive bacteria (Staphylococcus aureus and Bacillus cereus) by determining minimal inhitory concentration (MIC) and minimal bactericidal concentration (MBC) using the broth dilution method. Bacterial colonies were taken from fresh cultures and incubated in the tubes containing 5 mL of trypticase soy broth at 37˚C for 6 hours until achieving visible growth. Turbidity was adjusted to 0.5 McFarland standard by adding 0.05 mL of 1% w/v BaCl<sub>2</sub>&#183;2H<sub>2</sub>O in phosphate buffered saline (PBS) to 9.95 mL of 1% v/v H<sub>2</sub>SO<sub>4</sub> in PBS. Finally, 10 mg of each compound was dissolved in 10 mL of dimethyl sulfoxide (DMSO) to obtain concentration if 1 mg/mL [<xref ref-type="bibr" rid="scirp.124962-ref16">16</xref>] .</p></sec><sec id="s2_7"><title>2.7. Anticancer Activity to Breast Cancer Cell Line</title><p>By using MCF-7 cells during growth stage (9 &#215; 10<sup>4</sup> cells/mL) 45 μL. Add sample element 5 μL diluted by DMSO 5% mixed with 384-well plated and incubate at a temperature of 37˚C with 5% of CO<sub>2</sub> for 3 days, then add solution resazurin 62.5 μg/mL 12.5 μL, incubate 4 hours at a temperature of 37˚C. Then draw a graph for the relation between the concentration and the value of response of cells to find IC<sub>50</sub> [<xref ref-type="bibr" rid="scirp.124962-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.124962-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.124962-ref19">19</xref>] .</p></sec><sec id="s2_8"><title>2.8. Statistic</title><p>All experiments were carried out in triplicates. Data obtained were analyzed by using one-way analysis of variance (ANOVA) and Pearson’s correlation coefficient was performed. Significant differences between the means at 95% (p &lt; 0.05) level were considered statistically significant. Data was recorded as mean &#177; standard deviation.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Physicochemical Characterization of Samples</title><p>Physical chemistry feature of compound from synthesis, both ligands; syringaldehyde semicarbazone (L1), syringaldehyde thiosemicarbazone (L2), syringaldehyde isonicotinic acid hydrazone (L3), syringaldehyde nicotinic hydrazone (L4), syringaldehyde salicylic hydrazone (L5) and complex between ligands and copper (II) ion are C1, C2, C3, C4 and C5. The synthesized substances will have color, molecular formula, melting point, percentage of elemental substances, and percentage of products in different figures as in <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="table" rid="table2">Table 2</xref> respectively.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Percent yield, molecular weight and elemental analysis of samples</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Code</th><th align="center" valign="middle" >MW</th><th align="center" valign="middle" >% C</th><th align="center" valign="middle" >% H</th><th align="center" valign="middle" >% N</th></tr></thead><tr><td align="center" valign="middle" >L1</td><td align="center" valign="middle" >239.26</td><td align="center" valign="middle" >50.15<sup>* </sup> (49.67)<sup># </sup></td><td align="center" valign="middle" >5.43 (5.80)</td><td align="center" valign="middle" >17.55 (17.72)</td></tr><tr><td align="center" valign="middle" >C1</td><td align="center" valign="middle" >382.55</td><td align="center" valign="middle" >31.48 (31.37)</td><td align="center" valign="middle" >3.42 (3.40)</td><td align="center" valign="middle" >13.20 (13.33)</td></tr><tr><td align="center" valign="middle" >L2</td><td align="center" valign="middle" >255.32</td><td align="center" valign="middle" >46.69 (46.60)</td><td align="center" valign="middle" >5.09 (5.23)</td><td align="center" valign="middle" >16.45 (16.51)</td></tr><tr><td align="center" valign="middle" >C2</td><td align="center" valign="middle" >389.87</td><td align="center" valign="middle" >30.78 (30.65)</td><td align="center" valign="middle" >3.33 (3.30)</td><td align="center" valign="middle" >10.77 (10.70)</td></tr><tr><td align="center" valign="middle" >L3</td><td align="center" valign="middle" >301.32</td><td align="center" valign="middle" >59.74 (60.09)</td><td align="center" valign="middle" >4.98 (5.14)</td><td align="center" valign="middle" >13.94 (13.19)</td></tr><tr><td align="center" valign="middle" >C3</td><td align="center" valign="middle" >418.32</td><td align="center" valign="middle" >41.03 (41.29)</td><td align="center" valign="middle" >4.06 (3.77)</td><td align="center" valign="middle" >9.54 (9.55)</td></tr><tr><td align="center" valign="middle" >L4</td><td align="center" valign="middle" >301.32</td><td align="center" valign="middle" >59.74 (59.79)</td><td align="center" valign="middle" >4.98 (5.14)</td><td align="center" valign="middle" >13.24 (13.19)</td></tr><tr><td align="center" valign="middle" >C4</td><td align="center" valign="middle" >418.32</td><td align="center" valign="middle" >41.03 (40.88)</td><td align="center" valign="middle" >4.06 (3.77)</td><td align="center" valign="middle" >9.84 (9.85)</td></tr><tr><td align="center" valign="middle" >L5</td><td align="center" valign="middle" >316.33</td><td align="center" valign="middle" >60.69 (60.67)</td><td align="center" valign="middle" >5.06 (5.09)</td><td align="center" valign="middle" >8.85 (8.85)</td></tr><tr><td align="center" valign="middle" >C5</td><td align="center" valign="middle" >450.88</td><td align="center" valign="middle" >42.58 (42.50)</td><td align="center" valign="middle" >3.55 (3.50)</td><td align="center" valign="middle" >6.46 (6.21)</td></tr></tbody></table></table-wrap><p>*calc., #found.</p><p>All synthesized substances are polar compounds. But polarity is predominant in ligands (L1-L5). These ligands are reacted with copper (II) ions to form complexes (C1-C5) with reduced polarity due to is a reduced charge. This is caused by the neutralization of negatively charged ligands with positively charged copper (II) ion.</p><p>The hydrazonate Schiff base ligands employed in the present work were synthesized in good yields (80% - 91%) by the condensation reaction of corresponding syringaldehyde with selected hydrazide in methanolic solvent 1:1 stoichiometry. They yield green colored copper complexes when conjugated with CuCl<sub>2</sub>&#183;2H<sub>2</sub>O. Their compositional analyses indicate a general molecular formula as [M(ligand)(H<sub>2</sub>O)Cl] and absence of conductivity in DMSO solvent suggesting a nonelectrolyte nature for them.</p></sec><sec id="s3_2"><title>3.2. IR Spectra</title><p>The significant peaks in ir spectra of parent compounds and their probable assignments useful for determining the coordination mode of the present ligands are summarized in <xref ref-type="table" rid="table3">Table 3</xref>.</p><p>The parent syringaldehyde compound (precursor) exhibits the carbonyl stretching frequency at 1671 cm<sup>−1</sup> which is replaced after the condensation reaction by the imino stretching frequency at 1600 - 1699 cm<sup>−1</sup> and additional stretches at 957 - 976 cm<sup>−1</sup> due to hydrazinic N-N and C=O linkages respectively. The appearance of the ν (N-H) and ν (C=O) stretching vibrations indicate that in the solid state these ligands essentially exist in the keto form [<xref ref-type="bibr" rid="scirp.124962-ref20">20</xref>] . The broad band at 1600 - 1615 cm<sup>−1</sup> arises out of the vibrations of the delocalized (&gt;C=N-N=C&lt;) linkage [<xref ref-type="bibr" rid="scirp.124962-ref21">21</xref>] . The complexes also display a new band in the far-infrared region at 355 - 330 cm<sup>−1</sup> which can be assigned to stretching frequencies. Following metal complexation, the imino stretch is shifted to lower wave numbers whereas the hydrazinic N-N band shifts to higher wave numbers indicating participation of the azomethine group in copper complexation. The additional broad absorption observed in the visible 750 - 940 nm for copper complexes correspond to <sup>2</sup>B<sub>1g</sub> <sup>2</sup>B<sub>2g</sub> transition in the square planar environment in these compounds [<xref ref-type="bibr" rid="scirp.124962-ref22">22</xref>] .</p></sec><sec id="s3_3"><title>3.3. The Magnetic Susceptibility and Electron Spin Resonance (ESR) Data</title><p>When syringaldehyde hydrazonate copper complexes are calculated for ESR, it shows the results as in <xref ref-type="table" rid="table4">Table 4</xref>.</p><p>It well-known that x-band ESR spectra of copper (II) complexes can provide valuable information about the coordination environment around copper (II) ions. The spectra of four coordinate complexes in frozen DMSO glass show four resolved copper hyperfine lines which is indicative of monomeric copper (II) complexes having axial geometry. The calculations of ESR parameters yielding following relationship in the g values g<sub>//</sub> &gt; g<sub>^</sub> &gt; g<sub>e</sub> (2.0023) is consistent with a d<sub>x</sub><sup>2</sup>-<sub>y</sub><sup>2</sup> ground state in the square-planar environment similar to many analogous compounds reported in literature [<xref ref-type="bibr" rid="scirp.124962-ref23">23</xref>] . For copper (II) complexes the g<sub>//</sub> is a moderately sensitive function for indicating covalency. For the covalent complexes g<sub>//</sub> is less than 2.3 and for ionic environments it is normally 2.3 or larger. Present compounds showing g<sub>//</sub> is between 2.25 - 2.29 obviously have a significant covalent character in their metal-ligand bonds in agreement with the observation of Kivelson and Neiman [<xref ref-type="bibr" rid="scirp.124962-ref24">24</xref>] . The degree of distortion f (=g<sub>//</sub>/A<sub>//</sub>) appears to be an empirical index of deviation from idealized geometry. Values of 110 - 120 cm<sup>−1</sup> are typical for planar complexes, whereas the range 130 - 150 cm<sup>−1</sup> is characteristic of slight to moderate distortion and 180 - 250 cm<sup>−1</sup> indicate considerable distortion [<xref ref-type="bibr" rid="scirp.124962-ref25">25</xref>] . The present compounds found to be ranking from 142 - 177 cm<sup>−1</sup> suggestive of slight to moderate distortion in geometry.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> IR Spectra of syringaldehyde hydrazones ligands (L1-L5) and their copper complexes (C1-C5)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Compound</th><th align="center" valign="middle" >ν (N-H)</th><th align="center" valign="middle" >ν (C=O)</th><th align="center" valign="middle" >ν (N-N)</th><th align="center" valign="middle" >ν (C=N)</th><th align="center" valign="middle" >ν (C=N-N=C)</th><th align="center" valign="middle" >ν (C-O)</th><th align="center" valign="middle" >Cu-O</th><th align="center" valign="middle" >Cu-N</th></tr></thead><tr><td align="center" valign="middle" >precursor L1 C1 L2 C2 L3 C3 L4 C4 L5 C5</td><td align="center" valign="middle" >3282 3377 - 3229 - 3225 - 3222 - 3291 -</td><td align="center" valign="middle" >1671 (vs) 1699 (vs) - 1645 - 1653 - 1636 (vs) - 1642 -</td><td align="center" valign="middle" >- 976(w) 986(s) 957 986 964 980 960 (w) 976 963 (s) 974</td><td align="center" valign="middle" >- 1590(s) 1537 (s) 1550 1537 1587 1509 1586 (s) 1553 1587 1564</td><td align="center" valign="middle" >- - 1610 (sh) - 1600 (sh) - 1615 (sh) - 1609 (sh) - 1612</td><td align="center" valign="middle" >- - 1371(s) - - 1323 (s) - 1372 (s) - 1357</td><td align="center" valign="middle" >- - 561 - - 570 - 556 - 511</td><td align="center" valign="middle" >- - 482 - - 485 - 490 - 480</td></tr></tbody></table></table-wrap><p>vs = very strong, s = strong, sh = shoulder, w = weak.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> X-band ESR parameters on copper complexes of syringaldehyde hydrazones (C1-C5)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Compounds</th><th align="center" valign="middle"  colspan="5"  >X-band ESR parameters</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >g<sub>//</sub></td><td align="center" valign="middle"  rowspan="2"  >g<sub>^</sub></td><td align="center" valign="middle"  colspan="2"  >A<sub>//</sub> (G)</td><td align="center" valign="middle"  rowspan="2"  >f (cm)</td></tr><tr><td align="center" valign="middle" >mT</td><td align="center" valign="middle" >&#215;10<sup>−4</sup> cm<sup>−1 </sup></td></tr><tr><td align="center" valign="middle" >C1 C2 C3 C4 C5</td><td align="center" valign="middle" >2.25 2.25 2.29 2.28 2.25</td><td align="center" valign="middle" >2.07 2.07 2.06 2.06 2.07</td><td align="center" valign="middle" >12.09 11.55 15.11 15.12 12.06</td><td align="center" valign="middle" >127 121 162 161 127</td><td align="center" valign="middle" >177 177 142 142 177</td></tr></tbody></table></table-wrap><p>ESR data recorded at 77 K in DMSO solvent.</p></sec><sec id="s3_4"><title>3.4. Antioxidant Activities</title><p>The ability of anti-free radical activities by using the technique DPPH technique illustrate the results by the percentage of free radical caused from the reaction made between the substance used in experiment and solution DPPH, calculating the spectral absorbance value at λ<sub>max</sub> 517 nm, the wave length value that DPPH can highly absorb. It is found that the value of spectral absorbance is changed. Hence, the sample substance has anti-free radical effect by making reaction with solution DPPH [<xref ref-type="bibr" rid="scirp.124962-ref26">26</xref>] . The DPPH free radical receive electron or hydrogen free radical from the sample substance used in experiment, resulting consistency and changed to be independent atom which can be observed from the spectral absorbance at the λ<sub>max</sub> 517 nm. The calculation of inhibitory concentration 50% is illustrated in <xref ref-type="table" rid="table5">Table 5</xref></p><p>It is found that the novel Schiff base ligands have anti-free radical effect DPPH at a high percentage. All complexes showed anti-free radical DPPH and has concentration dependence. as the ligands but have lower proficiency than the ligands because of the bigger structure resulting the steric effect that makes it difficult to provide hydrogen free radical. For the results of anti-free radical activity by reducing Fe<sup>3+</sup> to be Fe<sup>2+</sup> (FRAP technique), it is revealed that both ligands and complexes can reduce Fe<sup>3+</sup> [<xref ref-type="bibr" rid="scirp.124962-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.124962-ref28">28</xref>] .</p></sec><sec id="s3_5"><title>3.5. Antibacterial Activities</title><p>Prepare solution of samples in different concentrations and test antibacterial growth ability for the type Escherichia coli, Klebsiella spp., Staphylococcus aureus and Bacillus cereus for 24 hours. Then measure clear zone which find the results as in <xref ref-type="table" rid="table6">Table 6</xref> for their copper complexes.</p><p>From <xref ref-type="table" rid="table6">Table 6</xref>, it is found that all 5 complexes have antibacterial effect for all tested strains, especially C3 and C5, good antibacterial effects against Staphylococcus aureus. Moreover, it is also found that all complexes have effects on the dose dependence in nature.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Value of IC<sub>50</sub> of sample substances of anti-free radical DPPH</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Samples</th><th align="center" valign="middle"  colspan="2"  >IC<sub>50</sub> (Inhibitory concentration 50%)</th></tr></thead><tr><td align="center" valign="middle" >DPPH</td><td align="center" valign="middle" >FRAP</td></tr><tr><td align="center" valign="middle" >SRA L1 C1 L2 C2 L3 C3 L4 C4 L5 C5</td><td align="center" valign="middle" >136.73<sup>a </sup> 43.31<sup>h </sup> 51.07<sup>g </sup> 50.03<sup>g</sup> 88.61<sup>b</sup> 75.93<sup>d</sup> 62.22<sup>f</sup> 29.92<sup>i </sup> 81.52<sup>c</sup> 81.18<sup>c</sup> 70.36<sup>e</sup></td><td align="center" valign="middle" >128.16<sup>a</sup> 69.93<sup>d</sup> 26.20<sup>h</sup> 69.99<sup>d</sup> 66.03<sup>e</sup> 90.16<sup>c </sup> 18.46<sup>j</sup> 65.16<sup>f</sup> 25.25<sup>i</sup> 95.21<sup>b</sup> 35.40<sup> </sup></td></tr><tr><td align="center" valign="middle" >C.V. (%)</td><td align="center" valign="middle" >2.43</td><td align="center" valign="middle" >1.59</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> The MIC and MBC of the synthesized Schiff bases against the tested bacteria</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Bacteria</th><th align="center" valign="middle"  rowspan="2"  >MIC and MBC (ppm)</th><th align="center" valign="middle"  colspan="5"  >Compounds</th></tr></thead><tr><td align="center" valign="middle" >C1</td><td align="center" valign="middle" >C2</td><td align="center" valign="middle" >C3</td><td align="center" valign="middle" >C4</td><td align="center" valign="middle" >C5</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Klebsiella spp.</td><td align="center" valign="middle" >MIC</td><td align="center" valign="middle" >4.50 &#177; 0.71</td><td align="center" valign="middle" >5.50 &#177; 0.71</td><td align="center" valign="middle" >1.50 &#177; 0.71</td><td align="center" valign="middle" >7.00 &#177; 0.00</td><td align="center" valign="middle" >3.00 &#177; 0.71</td></tr><tr><td align="center" valign="middle" >MBC</td><td align="center" valign="middle" >4.50 &#177; 0.71</td><td align="center" valign="middle" >5.80 &#177; 0.71</td><td align="center" valign="middle" >2.00 &#177; 0.00</td><td align="center" valign="middle" >7.50 &#177; 0.71</td><td align="center" valign="middle" >3.50 &#177; 0.00</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Pseudomonas aeruginosa</td><td align="center" valign="middle" >MIC</td><td align="center" valign="middle" >7.00 &#177; 0.00</td><td align="center" valign="middle" >8.50 &#177; 0.71</td><td align="center" valign="middle" >1.50 &#177; 0.00</td><td align="center" valign="middle" >1.50 &#177; 0.71</td><td align="center" valign="middle" >1.25 &#177; 0.00</td></tr><tr><td align="center" valign="middle" >MBC</td><td align="center" valign="middle" >8.50 &#177; 0.71</td><td align="center" valign="middle" >9.00 &#177; 0.00</td><td align="center" valign="middle" >2.50 &#177; 0.71</td><td align="center" valign="middle" >2.00 &#177; 0.00</td><td align="center" valign="middle" >1.50 &#177; 0.71</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Bacillus cereus</td><td align="center" valign="middle" >MIC</td><td align="center" valign="middle" >9.00 &#177; 0.00</td><td align="center" valign="middle" >7.50 &#177; 0.00</td><td align="center" valign="middle" >3.00 &#177; 0.00</td><td align="center" valign="middle" >8.00 &#177; 0.00</td><td align="center" valign="middle" >5.50 &#177; 0.71</td></tr><tr><td align="center" valign="middle" >MBC</td><td align="center" valign="middle" >9.50 &#177; 0.71</td><td align="center" valign="middle" >8.00 &#177; 0.00</td><td align="center" valign="middle" >3.50 &#177; 0.00</td><td align="center" valign="middle" >9.50 &#177; 0.71</td><td align="center" valign="middle" >5.50 &#177; 0.00</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Staphylococcus aureus</td><td align="center" valign="middle" >MIC</td><td align="center" valign="middle" >5.00 &#177; 0.00</td><td align="center" valign="middle" >11.00 &#177; 0.00</td><td align="center" valign="middle" >2.00 &#177; 0.00</td><td align="center" valign="middle" >3.50 &#177; 0.71</td><td align="center" valign="middle" >2.50 &#177; 0.71</td></tr><tr><td align="center" valign="middle" >MBC</td><td align="center" valign="middle" >5.50 &#177; 0.71</td><td align="center" valign="middle" >12.50 &#177; 0.71</td><td align="center" valign="middle" >2.50 &#177; 0.71</td><td align="center" valign="middle" >3.50 &#177; 0.71</td><td align="center" valign="middle" >3.50 &#177; 0.71</td></tr></tbody></table></table-wrap><p>Note: Values are expressed as Mean &#177; S.D (n = 3).</p></sec><sec id="s3_6"><title>3.6. Cytotoxicity to Normal and Breast Cancer Cells</title><p>The researcher used the complexes to test the effect of anti-breast cancer cell in metastasis stage (breast adenocarcinoma MCF-7 cell line). In addition, the researcher also studies whether the selected solution has poisonous effect to normal Vero cell line, as in <xref ref-type="table" rid="table7">Table 7</xref>.</p><p>From <xref ref-type="table" rid="table7">Table 7</xref>, it is revealed that the complex substances C1, C2, C3 and C4 are not poisonous to the normal cell except C5 which has poisonous effect in high concentrations. The effect of anti-breast cancer growth MCF-7 cell line is found that all sub stances have anti-cancer cell growth at a good effect with the value of IC<sub>50</sub>, low value, especially the C5 (IC<sub>50</sub> 9.75 μM). The efficiency of anti-cancer cell effect of sample substances ranking from much to less is as follows: C5 &gt; C2 &gt; C1 &gt; C4 &gt; C3.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>This research has synthesized and characterization of physicochemical properties, elucidation their effect as anti-free radical scavenging activities by using the DPPH and FRAP techniques, the screening of the in vitro antibacterial activity against two Gram-negative bacteria (Klebsiella spp. and Pseudomonas aeruginosa) and two Gram-positive bacteria (Bacillus cereus and Staphylococcus aureus) and anti-breast cancer MCF-7 cell line and also cytotoxicity condition to the normal Vero cell line on syringaldehyde hydrazone Schiff base ligands and their hydrazonate copper complexes. The results from the synthesis are found that both ligands and their complexes achieved at a high percentage and also found that the complexes are covalent and have a square-planar shape. Radical scavenging activity of the substances using the technique of DPPH is revealed that the syringaldehyde hydrazone Schiff base ligands have a very high ability on anti-free radical DPPH, but the syringaldehyde hydrazonate copper complexes have lower ability on anti-free radical than independent ligands. For anti-free</p><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Cytotoxicity of the syringaldehyde hydrazonate copper complexes to normal Vero cell and breast cancer cell line (MCF-7)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Complexes</th><th align="center" valign="middle"  colspan="2"  >cytotoxicity to Vero cell</th><th align="center" valign="middle"  colspan="2"  >cytotoxicity to MCF-7 cell line</th></tr></thead><tr><td align="center" valign="middle" >activity</td><td align="center" valign="middle" >IC<sub>50</sub> (μg/mL)</td><td align="center" valign="middle" >activity</td><td align="center" valign="middle" >IC<sub>50</sub> (μg/mL)</td></tr><tr><td align="center" valign="middle" >C1 C2 C3 C4 C5</td><td align="center" valign="middle" >noncytotoxic noncytotoxic noncytotoxic noncytotoxic cytotoxic</td><td align="center" valign="middle" >- - - - 49.11</td><td align="center" valign="middle" >active active active active active</td><td align="center" valign="middle" >15.25 12.46 23.37 20.24 9.75</td></tr></tbody></table></table-wrap><p>radical activity by reducing Fe<sup>3+</sup> to be Fe<sup>2+</sup> (FRAP) is found that ligands and their complexes show low ability to reduce iron because molecule has difficulty in providing single electron transfer. Antioxidants have a differing capacity to stop the propagation of free radicals the influencing this both the structure of the antioxidant and the structure of the compounds to be oxidized [<xref ref-type="bibr" rid="scirp.124962-ref29">29</xref>] . For antibacterial activity are found that ligand L1 can be antibacterial substances for the type Pseudomonas aeruginosa and ligand L5 can be antibacterial substance for the type Staphylococcus aureus (MRSA) and Bacillus cereus. For the complexes, it is revealed that all complexes against bacteria with concentrations dependence in manner. The disease caused from these bacteria is difficult to cure, especially caused from bacteria Staphylococcus aureus because these bacteria resist drug action to Methicillin taken nowadays. The results of this study are revealed that the L5 can be antibacterial growth. It is therefore a new interesting discovery and also a new hope for patients caused from bacteria Staphylococcus aureus [<xref ref-type="bibr" rid="scirp.124962-ref30">30</xref>] . The ability on anti-breast cancer MCF-7 and cytotoxicity condition to normal cell are found that nearly all chemical compound is not poisonous to normal cell except C5 which is poisonous at a high concentration. The effect against breast cancer growth MCF-7 cell line (human metastatic breast cancer) is found that all chemical compounds show significant inhibition against hormone dependent breast cancer cell line with IC<sub>50</sub> &lt; 25 μM, especially the C5 (IC<sub>50</sub> 9.75 μg/mL) as summarized in <xref ref-type="table" rid="table7">Table 7</xref>. Lending support to our earlier observation that copper is a key metal which helps in enhancing the biological activity [<xref ref-type="bibr" rid="scirp.124962-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.124962-ref32">32</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>The synthesis of both novel ligands and their metal-organic compounds showed achieving a high percentage of productivity. For complexes were covalent and had a flat rectangular shape (square planar). The higher DPPH radical scavenging activity was found in syringaldehyde hydrazone Schiff base ligands than syringaldehyde hydrazonate copper complexes. Regarding the antioxidant effect by reducing Fe<sup>3+</sup> to Fe<sup>2+</sup> (FRAP) of all compounds, it was found the ligands and complexes were less able to reduce iron. Antibacterial activities are clearly indicated that copper conjugation synergistically enhances the antibacterial activities of syringaldehyde hydrazone. Almost all compounds were non-toxic to normal cells except C5, which was toxic at high concentration. As for the anti-growth activity of human metastatic breast cancer cells (MCF-7 cell line), all compounds were effective against the growth of cancer cells.</p></sec><sec id="s6"><title>Acknowledgements</title><p>The financial support of this work by Rajabhat Buriram University is thankfully acknowledged. We also thank the National Center for Genetic Engineering and Biotechnology (BIOTEC), Scientific and Technological Research Equipment Centre (STREC) Chulalongkorn University, Thailand and Professor Dr. Subhash Padhye, University of Pune, India.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Patitungkho, S. and Patitungkho, K. (2023) Physicochemical Properties and Biological Activities of Novel Hydrazonate Copper Complexes. Open Journal of Medicinal Chemistry, 13, 1-13. https://doi.org/10.4236/ojmc.2023.131001</p></sec></body><back><ref-list><title>References</title><ref id="scirp.124962-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Carpenter, D.O. and Bushkin-Bedient, S. (2013) Exposure to Chemicals and Radiation during Childhood and Risk for Cancer Later in Life. Journal of Adolescent Health, 52, S21-S29. https://doi.org/10.1016/j.jadohealth.2013.01.027</mixed-citation></ref><ref id="scirp.124962-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Sugimura, T. (2000) Nutrition and Dietary Carcinogens. Carcinogenesis, 21, 387-395. https://doi.org/10.1093/carcin/21.3.387</mixed-citation></ref><ref id="scirp.124962-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Molina-Montes, E., Ubago-Guisada, E., Petrova, D., Amiano, P., Chirlaque, M.-D., Agudo, A. and Sánchez, M.-J. (2021) The Role of Diet, Alcohol, BMI and Physical Activity in Cancer Mortality: Summary Findings of the EPIC Study. Nutrients, 13, Article 4293. https://doi.org/10.3390/nu13124293</mixed-citation></ref><ref id="scirp.124962-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Basu, A.K. (2018) DNA Damage, Mutagenesis and Cancer. International Journal of Molecular Sciences, 19, Article 970. https://doi.org/10.3390/ijms19040970</mixed-citation></ref><ref id="scirp.124962-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Datta, N., Chakraborty, S., Basu, M. and Ghosh, M.K. (2020) Tumer Suppressors having Oncogenic Functions: The Double Agents. Cells, 10, Article 46. https://doi.org/10.3390/cells10010046</mixed-citation></ref><ref id="scirp.124962-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Barrios, C.H. (2022) Global Challenges in Breast Cancer Detection and Treatment. The Breast, 62, S3-S6. https://doi.org/10.1016/j.breast.2022.02.003</mixed-citation></ref><ref id="scirp.124962-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Brierley, J., O’Sullivan, B., Asamura, H., Burd, D., Huang, S.H., Lee, A., Pi&amp;#241;eros, M., Mason, M., Moraes, F.Y., R&amp;#246;sler, W., Rous, B., Torode, J., Krieken, J.H.V. and Gospodarowicz, M. (2019) Global Consultation on Cancer Staging: Promoting Consistent Understanding and Use. Nature Reviews Clinical Oncology, 16, 763-771. https://doi.org/10.1038/s41571-019-0253-x</mixed-citation></ref><ref id="scirp.124962-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Pourrahmat, M.-M., Kim, A., Kansal, A.R., Hux, M., Pushkarna, D., Fazeli, M.S. and Chung, K.C. (2021) Health State Utility Values by Cancer Stage: A Systematic Literature Review. European Journal of Health Economics, 22, 1275-1288. https://doi.org/10.1007/s10198-021-01335-8</mixed-citation></ref><ref id="scirp.124962-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Riggio, A.I., Varley, K.E. and Welm, A.L. (2021) The Lingering Mysteries of Metastatic Recurrence in Breast Cancer. British Journal of Cancer, 124, 13-26. https://doi.org/10.1038/s41416-020-01161-4</mixed-citation></ref><ref id="scirp.124962-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Tilsed, C.M., Fisher, S.A., Nowak, A.K., Lake, R.A. and Lesterhuis, W.J. (2022) Cancer Chemotherapy: Insights into Cellular and Tumor Microenvironmental Mechanisms of Action. Frontiers in Oncology, 12, Article 960317. https://doi.org/10.3389/fonc.2022.960317</mixed-citation></ref><ref id="scirp.124962-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Schirrmacher, V. (2019) From Chemotherapy to Biological Therapy: A Review of Novel Concept to Reduce the Side Effects of Systemic cancer Treatment. International Journal of Oncology, 54, 407-419. https://doi.org/10.3892/ijo.2018.4661</mixed-citation></ref><ref id="scirp.124962-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N. and Sarkar, S. (2014) Drug Resistance in Cancer: An Overview. Cancers, 6, 1769-1792. https://doi.org/10.3390/cancers6031769</mixed-citation></ref><ref id="scirp.124962-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Baker, R.E., Mahmud, A.S., Miller, I.F., Rajeev, M., Rasambainarivo, F., Rice, B.L., Takahashi, S., Tatem, A.J., Wagner, C.E., Wang, L.-F., Wesolowski, A. and Metcalf, C.J.E. (2022) Infectious Disease in an Era Global Change. Nature Reviews, 20, 193-205. https://doi.org/10.1038/s41579-021-00639-z</mixed-citation></ref><ref id="scirp.124962-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Lee, A.S., Lencastre, H.D., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A. and Harbarth, S. (2018) Methicillin-Resistant Staphylococcus aureus. Nature Reviews, 4, Article No. 18033. https://doi.org/10.1038/nrdp.2018.33</mixed-citation></ref><ref id="scirp.124962-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, N.K., Dey, S. and Prasad, R. (2007) In Vitro Antioxidant Potential Evaluation of Euphorbia hirta L. pharmacologyonline, 1, 91-98.</mixed-citation></ref><ref id="scirp.124962-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Melha, K.A. (2008) Antimicrobial, Spectral, Magnetic and Thermal Studies of Cu(II), Ni(II), Co(II), UO2(VI) and Fe(III) Complexes of the Schiff Base Derived from Oxalylhydrazide. Journal of Enzyme Inhibition and Medicinal Chemistry, 23, 285-295. https://doi.org/10.1080/14756360701448073</mixed-citation></ref><ref id="scirp.124962-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Vyas, A., Patitungkho, S., Jamadar, A., Adsule, S., Padhye, S., Ahmad, A. and Sarkar, F.H. (2012) ATRA-Hydrazonate Derivatives and Their Copper Complexes against Hormone-Dependent (MCF-7), Hormone-Independent (MDA-MB-231 and BT-20) Breast Cancer and Androgen-Independent (PC3) Prostate Cancer Cell lines. Inorganic Chemistry Communications, 23, 17-20. https://doi.org/10.1016/j.inoche.2012.05.027</mixed-citation></ref><ref id="scirp.124962-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Patitungkho, S., Adsule, S., Dandawate, P., Padhye, S., Ahmad, A. and Sarkar, F.H. (2011) Synthesis, Characterization and Anti-Tumor Activity of Moxifloxacin-Copper Complexes against Breast Cancer Cell Lines. Bioorganic Medicinal Chemistry Letters, 21, 1802-1806. https://doi.org/10.1016/j.bmcl.2011.01.061</mixed-citation></ref><ref id="scirp.124962-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Chaviara, A.T., Cox, P.J., Repana, K.H., Pantazaki, A.A., Papazisis, K.T., Kortsaris, A.H., Kyriakidis, D.A., Nikolov, G.S. and Bolos, C.A. (2005) The Unexpected Formation of Biologically Active Cu(II) Schiff Mono-Base Complexes with 2-Thiophene-Carboxaldehyde and Dipropylenetriamine: Crystal and Molecular Structure of CudptaSCl2. Journal of Inorganic Biochemistry. 99, 467-476. https://doi.org/10.1016/j.jinorgbio.2004.10.026</mixed-citation></ref><ref id="scirp.124962-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Nawar, N. and Hosney, N.M. (2000) Synthesis, Spectral and Antimicrobial Activity Studies of o-Aminoacetophenone o-Hydroxybenzoylhydrazone Complexes. Transition Metal Chemistry, 25, 1-8. https://doi.org/10.1023/A:1007080122211</mixed-citation></ref><ref id="scirp.124962-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Nakamoto, K. (2009) Infrared and Raman Spectra of Inorganic and Coordination Compounds Part A: Theory and Applications in Inorganic Chemistry. 6th Edition, John Wiley &amp; Sons, New Jersey. https://doi.org/10.1002/9780470405840</mixed-citation></ref><ref id="scirp.124962-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Lever, A.B.P. (1984) Inorganic Electronic Spectroscopy. 2nd Edition, Elsevier, Amsterdam.</mixed-citation></ref><ref id="scirp.124962-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Hathaway, B.J. and Billing, D.E. (1970) The Electronic Properties and Stereochemistry of Mono-Nuclear Complexes of the Copper(II) Ion. Coordination Chemistry Reviews, 5, 143-207. https://doi.org/10.1016/S0010-8545(00)80135-6</mixed-citation></ref><ref id="scirp.124962-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Kivelson, D. and Neiman, R. (1961) ESR Studies on the Bonding in Copper Complexes. The Journal of Chemical Physics, 35, 149-155. https://doi.org/10.1063/1.1731880</mixed-citation></ref><ref id="scirp.124962-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Yallur, B.C., Krishna, P.M. and Challa, M. (2021) Bivalent Ni(II), Co(II) and Cu(II) Complexes of [(E)-[(2-Methyl-1,3-Thiazol-5-yl)Methylidene]Amino]Thiourea: Synthesis, Spectral Characterization, DNA and in Vitro Anti-Bacterial Studies. Heliyon, 7, e06838. https://doi.org/10.1016/j.heliyon.2021.e06838</mixed-citation></ref><ref id="scirp.124962-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Salama, Z.A., Baz, F.K.E., Gaafar, A.A. and Zaki, M.F. (2015) Antioxidant Activities of Phenolics, Flavonoids and Vitamin C in Two Cultivars of Fennel (Foeniculum vulgare Mill.) in Responses to Organic and Bio-Organic Fertilizers. Journal of the Saudi Society of Agriculture Sciences, 14, 91-99. https://doi.org/10.1016/j.jssas.2013.10.004</mixed-citation></ref><ref id="scirp.124962-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Azieana, J., Zainon, M.N., Noriham, A. and Rohana, M.N. (2017) Total Phenolic and Flavonoid Content and Antioxidant Activities of Ten Malasian Wild Mushrooms. Open Access Library, 4, e3987. https://doi.org/10.4236/oalib.1103987</mixed-citation></ref><ref id="scirp.124962-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Ghasemzadeh, A., Jaafar, H.Z.E. and Rahmat, A. (2010) Antioxidant Activities, Total Phenolics and Flavonoids Content in Two Varieties of Malasia Young Ginger (Zingiber officinale Roscoe). Molecules, 15, 4324-4333. https://doi.org/10.3390/molecules15064324</mixed-citation></ref><ref id="scirp.124962-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Christodoulou, M.C., Palacios, J.C.O., Hesami, G., Jafarzadeh, S., Lorenzo, J.M., Dom&amp;#236;nguez, R., Moreno, A. and Hadidi, M. (2022) Spectrophotometric Methods for Measurement of Antioxidant Activity in Food and Pharmaceuticals. Antioxidants, 11, Article 2213. https://doi.org/10.3390/antiox11112213</mixed-citation></ref><ref id="scirp.124962-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Ommenya, F.K., Nyawade, E.A., Andala, D.M. and Kinyua, J. (2020) Synthesis, Characterization and Antibacterial Activity of Schiff Base, 4-Chloro-2-{E-[(4-Fluorophenyl)Imino]Methyl}Phenol Metal (II) Complexes. Journal of Chemistry, 2020, Article ID: 1745236. https://doi.org/10.1155/2020/1745236</mixed-citation></ref><ref id="scirp.124962-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Zambre, A., Kulkarni, V.M., Padhye, S., Sandur, S.K. and Aggarwal, B.B. (2006) Novel Curcumin Analogs Targeting TNF-Induced NF-κB Activation and Proliferation in Human Leukemic KBM-5 Cells. Bioorganic Medicinal Chemistry, 14, 7196-7204. https://doi.org/10.1016/j.bmc.2006.06.056</mixed-citation></ref><ref id="scirp.124962-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Ambike, V., Adsule, S., Ahmed, F., Wang, Z., Afrasiabi, Z., Sinn, E., Sarkar, F. and Padhye, S. (2007) Copper Conjugates of Nimsulide Schiff Bases Targeting VEGF, COX and Bcl-2 in Pancreatic Cancer Cells. Journal of Inorganic Biochemistry, 101, 1517-1524. https://doi.org/10.1016/j.jinorgbio.2007.06.028</mixed-citation></ref></ref-list></back></article>